Antiplatelet and statin use in US patients with coronary artery disease categorized by race/ethnicity and gender, 2003 to 2012

American Journal of Cardiology

Volumn 115, Issue 11, 2015, Pages 1507-1512

  Johansen, Michael E ^a   Hefner, Jennifer L ^a   Foraker, Randi E ^b  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID PLUS DIPYRIDAMOLE; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PRASUGREL; TICLOPIDINE; WARFARIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; DRUG USE; FEMALE; HEALTH CARE POLICY; HEALTH CARE SURVEY; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RACE DIFFERENCE; SEX DIFFERENCE; SOCIAL STATUS; UNITED STATES; AFRICAN AMERICAN; CAUCASIAN; COMPARATIVE STUDY; DRUG COMBINATION; HEALTH CARE DISPARITY; HISPANIC; MIDDLE AGED; SOCIOECONOMICS; TIME;

AFRICAN AMERICANS; AGED; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; DRUG THERAPY, COMBINATION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTHCARE DISPARITIES; HISPANIC AMERICANS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; SEX FACTORS; SOCIOECONOMIC FACTORS; TIME FACTORS; UNITED STATES;

EID: 84929296222     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2015.02.052     Document Type: Article

References (30)

1. C.W. Yancy, T.Y. Wang, H.O. Ventura, I.L. Piña, K. Vijayaraghavan, K.C. Ferdinand, L.L. Hall credo Advisory Group The coalition to reduce racial and ethnic disparities in cardiovascular disease outcomes (credo): why credo matters to cardiologists J Am Coll Cardiol 57 2011 245 252
2. J. Lewey, W.H. Shrank, A.D. Bowry, E. Kilabuk, T.A. Brennan, and N.K. Choudhry Gender and racial disparities in adherence to statin therapy: a meta-analysis Am Heart J 165 2013 665 678 678.e1
3. D.M. Qato, S.T. Lindau, R.M. Conti, L.P. Schumm, and G.C. Alexander Racial and ethnic disparities in cardiovascular medication use among older adults in the United States Pharmacoepidemiol Drug Saf 19 2010 834 842
4. A.K. Jha, P.D. Varosy, A.M. Kanaya, D.B. Hunninghake, M.A. Hlatky, D.D. Waters, C.D. Furberg, and M.G. Shlipak Differences in medical care and disease outcomes among black and white women with heart disease Circulation 108 2003 1089 1094
5. J.C. Lauffenburger, J.G. Robinson, C. Oramasionwu, and G. Fang Racial/Ethnic and gender gaps in the use of and adherence to evidence-based preventive therapies among elderly Medicare Part D beneficiaries after acute myocardial infarction Circulation 129 2014 754 763
6. G.N. Graham, C.W. Yancy, A.K. Boehm, and M.H. Wendt Cardiovascular care in an increasingly diverse community Circulation 125 2012 1037 1042
7. M.G. George, X. Tong, N. Sonnenfeld, Y. Hong Centers for Disease Control and Prevention (CDC) Recommended use of aspirin and other antiplatelet medications among adults-National ambulatory medical care survey and national hospital ambulatory medical care survey, United States, 2005-2008 MMWR Morb Mortal Wkly Rep 61 suppl 2012 11 18
8. N.K. Wenger Women and coronary heart disease: a century after Herrick: understudied, underdiagnosed, and undertreated Circulation 126 2012 604 611
9. Medical Expenditure Panel Survey. 2012 Consolidated Data File. Available at: http://meps.ahrq.gov/mepsweb/data-stats/download-data/pufs/h155/h155doc.pdf. Accessed on October 21, 2014.
10. S.C. Hill, S.H. Zuvekas, and M.W. Zodet Implications of the accuracy of MEPS prescription drug data for health services research Inquiry 48 2011 242 259
11. M.E. Johansen, L.A. Green, A. Sen, S. Kircher, and C. Richardson Cardiovascular risk and statin use in the United States: a cross-sectional analysis Ann Fam Med 12 2014 215 223
12. J. Ma, N.L. Sehgal, J.Z. Ayanian, and R.S. Stafford National trends in statin use by coronary heart disease risk category PLoS Med 2 2005 e123
13. D.C. Goff Jr., L. Gu, L.K. Cantley, D.J. Sheedy, and S.J. Cohen Quality of care for secondary prevention for patients with coronary heart disease: results of the hastening the effective application of research through technology (heart) trial Am Heart J 146 2003 1045 1051
14. S.V. Arnold, J.A. Spertus, F. Tang, H.M. Krumholz, W.B. Borden, S.A. Farmer, H.H. Ting, and P.S. Chan Statin use in outpatients with obstructive coronary artery disease Circulation 124 2011 2405 2410
15. J.B. Brown, T.E. Delea, G.A. Nichols, J. Edelsberg, P.J. Elmer, and G. Oster Use of oral antithrombotic agents among health maintenance organization members with atherosclerotic cardiovascular disease Arch Intern Med 162 2002 193 199
16. P.J. Connor, N.P. Pronk, A.W. Tan, W.A. Rush, and R.J. Gray Does professional advice influence aspirin use to prevent heart disease in an HMO population? Eff Clin Pract 1 1998 26 32
17. A.G. Mainous, R.J. Tanner, R.I. Shorr, and M.C. Limacher Use of aspirin for primary and secondary cardiovascular disease prevention in the United States, 2011-2012 J Am Heart Assoc 3 2014
18. R.S. Stafford, V. Monti, and J. Ma Underutilization of aspirin persists in US ambulatory care for the secondary and primary prevention of cardiovascular disease PLoS Med 2 2005 e353
19. H. Mochari-Greenberger, M. Liao, and L. Mosca Racial and ethnic differences in statin prescription and clinical outcomes among hospitalized patients with coronary heart disease Am J Cardiol 113 2014 413 417
20. S.V. Arnold, M. Kosiborod, F. Tang, Z. Zhao, T.M. Maddox, P.L. McCollam, J. Birt, and J.A. Spertus Patterns of statin initiation, intensification, and maximization among patients hospitalized with an acute myocardial infarction Circulation 129 2014 1303 1309
21. W.R. Lewis, E.D. Peterson, C.P. Cannon, D.M. Super, K.A. LaBresh, K. Quealy, L. Liang, and G.C. Fonarow An organized approach to improvement in guideline adherence for acute myocardial infarction: results with the Get with the Guidelines quality improvement program Arch Intern Med 168 2008 1813 1819
22. K.M. Rose, R.E. Foraker, G. Heiss, W.D. Rosamond, C.M. Suchindran, and E.A. Whitsel Neighborhood socioeconomic and racial disparities in angiography and coronary revascularization: the ARIC surveillance study Ann Epidemiol 22 2012 623 629
23. G.A. Mensah, A.H. Mokdad, E.S. Ford, K.J. Greenlund, and J.B. Croft State of disparities in cardiovascular health in the United States Circulation 111 2005 1233 1241
24. N.R. Kressin, and L.A. Petersen Racial differences in the use of invasive cardiovascular procedures: review of the literature and prescription for future research Ann Intern Med 135 2001 352 366
25. M.D. Wong, M.F. Shapiro, W.J. Boscardin, and S.L. Ettner Contribution of major diseases to disparities in mortality N Engl J Med 347 2002 1585 1592
26. J.M. Ruiz, P. Steffen, and T.B. Smith Hispanic mortality paradox: a systematic review and meta-analysis of the longitudinal literature Am J Public Health 103 2013 e52 60
27. C.N. Bairey Merz, L.J. Shaw, S.E. Reis, V. Bittner, S.F. Kelsey, M. Olson, D. Johnson, C.J. Pepine, S. Mankad, B.L. Sharaf, W.J. Rogers, G.M. Pohost, A. Lerman, A.A. Quyyumi, G. Sopko for the WISE Investigators Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study. Part II: gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease J Am Coll Cardiol 47 2006 21S 29S
28. H. Jneid, G.C. Fonarow, C.P. Cannon, A.F. Hernandez, I.F. Palacios, A.O. Maree, Q. Wells, B. Bozkurt, G. Fletcher, E. Peterson, L. Wexler for the Get with the Guidelines Steering Committee and Investigators Sex differences in medical care and early death after acute myocardial infarction Circulation 118 2008 2803 2810
29. R. Bugiardini, A.T. Yan, R.T. Yan, D. Fitchett, A. Langer, O. Manfrini, S.G. Goodman on behalf of the Canadian Acute Coronary Syndrome Registry I and II Investigators Factors influencing underutilization of evidence-based therapies in women Eur Heart J 32 2011 1337 1344
30. L. Mosca, E.J. Benjamin, K. Berra, J.L. Bezanson, R.J. Dolor, D.M. Lloyd-Jones, L.K. Newby, I.L. Piña, V.L. Roger, L.J. Shaw, D. Zhao, T.M. Beckie, C. Bushnell, J. D'Armiento, P.M. Kris-Etherton, J. Fang, T.G. Ganiats, A.S. Gomes, C.R. Gracia, C.K. Haan, E.A. Jackson, D.R. Judelson, E. Kelepouris, C.J. Lavie, A. Moore, N.A. Nussmeier, E. Ofili, S. Oparil, P. Ouyang, V.W. Pinn, K. Sherif, S.C. Smith Jr., G. Sopko, N. Chandra-Strobos, E.M. Urbina, V. Vaccarino, and N.K. Wenger Effectiveness-based guidelines for the prevention of cardiovascular disease in women - 2011 update: a guideline from the American Heart Association Circulation 123 2011 1243 1262